Effectiveness of the adapted bivalent mRNA COVID-19 vaccines against hospitalisation in individuals aged ≥ 60 years during the Omicron XBB lineage-predominant period: VEBIS SARI VE network, Europe, February to August, 2023

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F65269705%3A_____%2F24%3A00079585" target="_blank" >RIV/65269705:_____/24:00079585 - isvavai.cz</a>

Alternative codes found

RIV/00216224:14110/24:00135383

Result on the web

<a href="https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2024.29.3.2300708" target="_blank" >https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2024.29.3.2300708</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.2807/1560-7917.ES.2024.29.3.2300708" target="_blank" >10.2807/1560-7917.ES.2024.29.3.2300708</a>

Result language

angličtina

Original language name

Effectiveness of the adapted bivalent mRNA COVID-19 vaccines against hospitalisation in individuals aged ≥ 60 years during the Omicron XBB lineage-predominant period: VEBIS SARI VE network, Europe, February to August, 2023

Original language description

We conducted a multicentre hospital -based test -negative case-control study to measure the effectiveness of adapted bivalent COVID-19 mRNA vaccines against PCR-confirmed SARS-CoV-2 infection during the Omicron XBB lineage -predominant period in patients aged &gt;= 60 years with severe acute respiratory infection from five countries in Europe. Bivalent vaccines provided short-term additional protection compared with those vaccinated &gt; 6 months before the campaign: from 80% (95% CI: 50 to 94) for 14-89 days post -vaccination, 15% (95% CI: -12 to 35) at 90-179 days, and lower to no effect thereafter.

Czech name

—

Czech description

—

Type

J_imp - Article in a specialist periodical, which is included in the Web of Science database

CEP classification

—

OECD FORD branch

30303 - Infectious Diseases

Project

<a href="/en/project/LM2023049" target="_blank" >LM2023049: Czech National Node of the European Clinical Research Infrastructures Network</a><br>

Continuities

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year

2024

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Eurosurveillance

ISSN

1025-496X

e-ISSN

1560-7917

Volume of the periodical

29

Issue of the periodical within the volume

3

Country of publishing house

SE - SWEDEN

Number of pages

8

Pages from-to

2300708

UT code for WoS article

001199954400004

EID of the result in the Scopus database

2-s2.0-85182860062